Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=7499061

Benefits and risks of co-trimoxazole (Bacterim®) therapy

Author
LODE, H; MARGET, W
Freie Univ. Berlin, Klinikum Steglitz, Berlin 1000, Germany
Hoffman-La Roche AG, Germany (Funder/Sponsor)
Source

Infection. 1987, Vol 15, pp 221-266 ; suppl. 5 ; ref : dissem

CODEN
IFTNAL
ISSN
0300-8126
Scientific domain
Microbiology, infectious diseases; Tropical medicine
Publisher
Springer, Heidelberg
Publication country
Germany
Document type
Serial Issue
Language
English
Keyword (fr)
Antibactérien Association médicamenteuse Chimiothérapie Efficacité traitement Facteur risque Foie pathologie Homme Hypersensibilité Peau pathologie Sang Sulfaméthoxazole Sulfonamide Toxicité Triméthoprime Bactrim
Keyword (en)
Antibacterial agent Drug combination Chemotherapy Therapeutic efficiency Risk factor Hepatic disease Human Hypersensitivity Skin disease Blood Sulfonamide Toxicity
Keyword (es)
Antibacteriano Asociación medicamentosa Quimioterapia Eficacidad tratamiento Factor riesgo Hígado patología Hombre Hipersensibilidad Piel patología Sangre Sulfonamida Toxicidad
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02S Antibiotics. Antiinfectious agents. Antiparasitic agents / 002B02S02 Antibacterial agents

Discipline
Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
7499061

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Searching the Web